CLINICAL_TRIALS
trial_result
· 2010-09-16
Clinical Trial Update: A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]
Summary
A Phase 3 study evaluating memantine for moderate to severe Alzheimer's disease has completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Dementia of the Alzheimer's Type | Phase 3 | Status: COMPLETED | Results posted: 2010-09-16